| DC Field | Value | Language |
|---|
| dc.contributor.author | Mirzoyan, N. R. | - |
| dc.contributor.author | Khostikyan, N. G. | - |
| dc.contributor.author | Meliksetyan, V. S. | - |
| dc.contributor.author | Hakobyan, A. A. | - |
| dc.contributor.author | Ganshina, T. S. | - |
| dc.date.accessioned | 2022-05-11T08:42:28Z | - |
| dc.date.available | 2022-05-11T08:42:28Z | - |
| dc.date.issued | 2021 | - |
| dc.identifier.citation | Neuroprotective and cerebrovascular effects of endogenous N-Arachidonoyl-GABA and its putative Cox-2 metabolite - GABA conjugate with Prostaglandin E2 / N.R. Mirzoyan [et al.] // Research Results in Pharmacology. - 2021. - Vol.7, №3.-P. 49-61. - Doi: 10.3897/rrpharmacology.7.70974. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46652 | - |
| dc.description.abstract | The aim of the study was to compare the neuroprotective and cerebrovascular effects of bioactive, endogenous lipid-N-arachidonoyl-GABA (AA-GABA) and GABA conjugate with prostaglandin E2 (PGE2-GABA) by evaluation of a morphological state of rat brain tissue and lipofuscin levels under the condition of permanent focal brain ischemia, as well as cerebral circulation under the condition of global transient ischemia | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | PGE2-GABA | ru |
| dc.subject | AA-GABA | ru |
| dc.subject | nimodipine | ru |
| dc.subject | ethylmethylhydroxypyridine succinate (mexidol) | ru |
| dc.subject | focal permanent ischemia | ru |
| dc.subject | global transient ischemia | ru |
| dc.subject | brain tissue | ru |
| dc.subject | lipofuscin | ru |
| dc.subject | cerebral blood flow | ru |
| dc.subject | bicuculline | ru |
| dc.title | Neuroprotective and cerebrovascular effects of endogenous N-Arachidonoyl-GABA and its putative Cox-2 metabolite - GABA conjugate with Prostaglandin E2 | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 7, № 3
|
